Literature DB >> 6174669

Specificity studies on cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis of monoclonal cytolytic T lymphocytes.

F Plata.   

Abstract

The specificities of cloned cytolytic T lymphocytes (CTL) were studied for the analysis of CTL populations generated against murine leukemia viruses (MuLV) in H-2 congenic BALB/c (H-2d) and BALB.B (H-2b) mice. In particular, CTL generated in response to tumors induced by Gross MuLV and Friend MuLV were studied; these tumors expressed virus-induced antigens that do not cross-react and that can be distinguished from each other. The systematic study of 92 CTL clones clearly indicated that MuLV-immune CTL were highly heterogeneous with respect to both the intensities of target cell lysis that they mediated and to their specificity of recognition of MuLV-induced tumor target cells. Various categories of CTL clones were identified, ranging from CTL clones tht were tightly H-2 restricted and specific for the immunizing tumor to CTL clones that displayed no discernible patterns of specificity and that attacked a large number of different target cells. In addition, the surface markers of these cloned CTL were defined, and the best conditions for their prolonged maintenance in culture were determined. The present data indicate that future efforts in the definition of target antigens recognized by tumor-specific CTL should be performed with monoclonal lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174669      PMCID: PMC2186662          DOI: 10.1084/jem.155.4.1050

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2.

Authors:  K J Blank; H A Freedman; F Lilly
Journal:  Nature       Date:  1976-03-18       Impact factor: 49.962

2.  Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.

Authors:  R B Herberman; T Aoki; M Nunn; D H Lavrin; N Soares; A Gazdar; H Holden; K S Chang
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

3.  The G (Gross) leukemia antigen.

Authors:  L J Old; E A Boyse; E Stockert
Journal:  Cancer Res       Date:  1965-07       Impact factor: 12.701

4.  Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors.

Authors:  J P Glynn; J L McCoy; A Fefer
Journal:  Cancer Res       Date:  1968-03       Impact factor: 12.701

5.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

6.  Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo.

Authors:  F Plata; B Sordat
Journal:  Int J Cancer       Date:  1977-02-15       Impact factor: 7.396

7.  Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.

Authors:  F Plata; C V Jongeneel
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

8.  Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.

Authors:  E Gomard; V Duprez; T Reme; M J Colombani; J P Levy
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

10.  Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice.

Authors:  H A Freedman; F Lilly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  4 in total

1.  Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells.

Authors:  T Ohno
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

2.  Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells.

Authors:  M Iwashiro; T Kondo; T Shimizu; H Yamagishi; K Takahashi; Y Matsubayashi; T Masuda; A Otaka; N Fujii; A Ishimoto
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

3.  Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.

Authors:  W Schmidt; H Festenstein
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes.

Authors:  H Tsurushima; S Q Liu; K Tuboi; A Matsumura; Y Yoshii; T Nose; K Saijo; T Ohno
Journal:  Jpn J Cancer Res       Date:  1999-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.